SEC Form 4 · accession 0001209191-15-072563
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Lindemoen
Officer — SVP Sales and Client Services
Period of report
Sep 28, 2015
Accepted (ET)
Sep 30, 2015 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF1 | Sep 28, 2015 | F | 3,558 | $28.49 | D | 21,799 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $33.2210 to $33.2920, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.